TEDCO, Maryland’s economic engine for technology companies, announced today that Astek Diagnostics Inc. (Astek), a Maryland Innovation Initiative (MII) portfolio company was accepted into the Y Combinator (YC).
TEDCO, Maryland’s economic engine for technology companies, released its 25th episode of its virtual series with CEO, Troy LeMaile-Stovall, called TEDCO Talks. The series features LeMaile-Stovall interviewing various thought leaders with connections to Maryland’s innovation ecosystem.
TEDCO recently launched ‘TEDCO Talks’, a series featuring thought leaders in economic development across the State of Maryland. On May 28th, TEDCO CEO & Executive Director, Troy LeMaile-Stovall interviewed Sally Allain, Head of JLABS @ Washington DC, about the future of the innovation ecosystem and the crucial role that JLABS will play in advancing the BioHealth Capital Region.
Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the closing of a $16.6 million Series A financing. The round was led by Hatteras Venture Partners with participation from Genesys Capital, Point Field Partners and Alexandria Venture Investments as well as support from previous Veralox investors including Sanofi Ventures, JDRF T1D Fund, Maryland Momentum Fund, VTC Innovation Fund and TEDCO. The Company also announced that Ben Scruggs, PhD, principal at Hatteras Venture Partners, and Jamie Stiff, MBA, managing director at Genesys Capital, will join the Veralox Therapeutics board of directors.
The Maryland Stem Cell Research Commission (Commission) announces the appointment of Amritha Jaishankar, PhD as Executive Director, Maryland Stem Cell Research Fund (MSCRF).
The Maryland Stem Cell Research Commission (Commission) has approved funding to its second round of 2021 recipients for a total of $6,052,901. The Commission has also appointed Amritha Jaishankar, Ph.D., the current MSCRF Director – Programs & Strategic Alliances, to succeed Dan Gincel, Ph.D., as Executive Director of the MSCRF, effective May 14, 2021.
TEDCO’s Dr. Arti Santhanam: Bringing New Innovations to Market TEDCO Drives Tech Commercialization Among University PartnersI95 BUSINESSBy Kristi S. HalfordApr 13, 2021Technology | Venture Capital + Angel Investors | Medical Innovation In 2012 when [….]
TEDCO, Maryland’s economic engine for technology companies, announced today the appointment of Jack Miner as the chief investment officer. He begins his tenure with TEDCO on March 1, 2021.
Dr. Amritha Jaishankar serves as the Director, Programs and Strategic Alliances, Maryland Stem Cell Research Fund (MSCRF). In this role, Amritha is responsible for oversight of programs, scientific management, and oversight of the portfolio, as well as MSCRF business development. She works with stem cell scientists across Maryland to develop a collaborative research program and promote commercialization of stem cell technologies.
2020 brought about a lot of growth across the BioHealth Capital Region (BHCR) as dozens of organizations responded with urgency to address the COVID-19 pandemic.
